{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:43:11Z","timestamp":1773409391565,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":543,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jfma.2012.07.036","type":"journal-article","created":{"date-parts":[[2012,8,25]],"date-time":"2012-08-25T07:46:21Z","timestamp":1345880781000},"page":"577-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases"],"prefix":"10.1016","volume":"113","author":[{"given":"Yu-Yun","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chih","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Lii","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2012.07.036_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jfma.2012.07.036_bib2","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1002\/cncr.25257","article-title":"Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma","volume":"116","author":"Shao","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jfma.2012.07.036_bib3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.bjc.6605580","article-title":"Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma","volume":"102","author":"Hsu","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jfma.2012.07.036_bib4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00384-006-0185-7","article-title":"Long-term survival after resection of extrahepatic recurrence of hepatocellular carcinoma at the right colon","volume":"22","author":"Ng","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jfma.2012.07.036_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1752-1947-2-222","article-title":"Long-term survival in a patient with repeated resections for lung metastasis after hepatectomy for ruptured hepatocellular carcinoma: a case report","volume":"2","author":"Shih","year":"2008","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.jfma.2012.07.036_bib6","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1200\/JCO.2010.32.6785","article-title":"Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report","volume":"29","author":"Curtit","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664612003919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664612003919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T07:29:23Z","timestamp":1542785363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664612003919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0929664612003919"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2012.07.036","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2012.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier (Singapore) Pte Ltd.","name":"copyright","label":"Copyright"}]}}